You just read:

Boehringer Ingelheim (Canada) Ltd.'s Targeted Lung Cancer Therapy, GIOTRIF® (afatinib), Recognized with Prestigious Prix Galien Canada - Innovative Product Award

News provided by

Boehringer Ingelheim (Canada) Ltd.

Nov 26, 2015, 08:00 ET